Ovidio Fernandez-Calvo

3PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 08, 2025
Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD study.

Ovidio Fernández, Aurea Molina, Urbano Anido-Herranz

|Sep 12, 2024
Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer.

Ovidio Fernández Calvo, José Muñoz Iglesias, Estephany Abou Jokh Casas

|Jul 27, 2024
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer.

Enrique Perez-Navarro, Vincenza Conteduca, Juan M Funes

Pageof 1

Frequent Collaborators

1 joint publications

José Muñoz Iglesias

1 joint publications

Estephany Abou Jokh Casas

1 joint publications

Urbano Anido Herranz

1 joint publications

Javier Casas Nebra